CPRiL

C30H34N8

C1CCN(C1)[C@H]2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76

InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1

• Bemcentinib
• 1037624-75-1
• R428
BGB-324
BGB324
R-428
Bemcentinib (GMP)
Bemcentinib [USAN]
0ICW2LX8AS
(S)-1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine
BemcentinibR428BGB324)
CS-1046
HY-15150
QC-11751
CHEMBL3809489
W-5845
SYN-1131
KB-80319
1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo(6,7)cyclohepta(1,2-C)pyridazin-3-yl)-N3-((7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl)-
1-(3,4-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,12,14-hexaen-5-yl)-~{N}3-[(7~{S})-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine
R 428
UNII-0ICW2LX8AS
SYN1131
1-{3,4-DIAZATRICYCLO[9.4.0.0(2),?]PENTADECA-1(11),2(7),3,5,12,14-HEXAEN-5-YL}-N3-[(7S)-7-(PYRROLIDIN-1-YL)-6,7,8,9-TETRAHYDRO-5H-BENZO[7]ANNULEN-2-YL]-1,2,4-TRIAZOLE-3,5-DIAMINE
Q8U
Bemcentinib (R428)
BEMCENTINIB [INN]
Bemcentinib (USAN/INN)
BEMCENTINIB [WHO-DD]
SCHEMBL1639904